Daphila, Dasatinib

Daphila is used for the treatment of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL).

Daphila is known as an anti cancer medicine, Daphila is known as a tyrosine kinase inhibitor. Daphila works by blocking the chemical messengers (called tyrosine kinases) which send signals to cells to grow. This in turn stops the cancerous cells growing and increasing in number.

Some of the potential side effects of Daphila can include the symptoms below;

Breathing difficulty,
Anemia,
Fatigue,
Infection,
Nausea,
Rash,
Headache,
Edema,
Reduced blood platelets,
Musculoskeletal pain,
Vomiting,
Abdominal pain,
Fever,
Bleeding.